Division of Neurology, Department of Brain and Neurological Sciences, Faculty of Medicine, Tottori University, 36-1 Nishicho, Yonago 683-8504, Japan.
Parkinsonism Relat Disord. 2012 May;18(4):394-6. doi: 10.1016/j.parkreldis.2011.10.018. Epub 2011 Nov 23.
Rapid eye movement (REM) sleep behaviour disorder (RBD) is an important indicator of underlying synucleinopathies. However, the frequency of RBD in tauopathies such as progressive supranuclear palsy (PSP) remains unclear. In this study, we compared RBD-related symptoms and polysomnographic (PSG) findings between patients with PSP and those with Parkinson's disease (PD).
We conducted clinical interviews of 20 patients with PSP, 93 patients with PD and their caregivers regarding RBD-related symptoms, and conducted PSG recordings on all the subject patients. We then compared the clinical backgrounds, PSG parameters, and frequency of RBD-related symptoms between the two groups.
PSP patients had more severe symptoms of Parkinsonism and cognitive impairment, and took lower doses of dopaminergic agents compared with PD patients. The PSP group had lower values for both estimated total sleep time and sleep efficiency on PSG compared with the PD group (p = 0.002, p = 0.021, respectively). The PSP group also included a significantly smaller number of patients having REM sleep without atonia (RWA) compared with the PD group (n = 5, 20.0% vs. n = 56, 60.2%, p = 0.003). None of the PSP patients were experiencing RBD-related symptoms at the time of the investigation, while 30 PD patients (32.3%) had RBD-related symptoms.
The existence of RWA as well as RBD-related symptoms was less frequent in patients with PSP versus patients with PD. Differences in brain stem pathology and/or disease course between the two disorders might influence this difference.
快速眼动(REM)睡眠行为障碍(RBD)是潜在突触核蛋白病的重要指标。然而,在tau 病如进行性核上性麻痹(PSP)中 RBD 的频率尚不清楚。在这项研究中,我们比较了 PSP 患者和帕金森病(PD)患者的 RBD 相关症状和多导睡眠图(PSG)发现。
我们对 20 例 PSP 患者、93 例 PD 患者及其照料者进行了 RBD 相关症状的临床访谈,并对所有受试者进行了 PSG 记录。然后,我们比较了两组的临床背景、PSG 参数和 RBD 相关症状的频率。
PSP 患者的帕金森病和认知障碍症状更严重,多巴胺能药物的剂量也更低。与 PD 组相比,PSP 组 PSG 中的估计总睡眠时间和睡眠效率值均较低(p = 0.002,p = 0.021)。与 PD 组相比,PSP 组 REM 睡眠无动性(RWA)患者的数量也明显较少(n = 5,20.0% vs. n = 56,60.2%,p = 0.003)。在调查时,没有 PSP 患者出现 RBD 相关症状,而 30 例 PD 患者(32.3%)出现 RBD 相关症状。
与 PD 患者相比,PSP 患者的 RWA 以及 RBD 相关症状的存在频率较低。两种疾病之间脑干病理学和/或病程的差异可能影响这种差异。